» Articles » PMID: 18842713

The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-mediated Restriction of Replication by Acting As an Antigen Decoy and Through Effects on Fc Receptor-bearing Leukocytes

Overview
Journal J Virol
Date 2008 Oct 10
PMID 18842713
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) readily infects and reinfects during infancy and throughout life, despite maternal antibodies and immunity from prior infection and without the need for significant antigenic change. RSV has two neutralization antigens, the F and G virion glycoproteins. G is expressed in both membrane-bound (mG) and secreted (sG) forms. We investigated whether sG might act as a decoy for neutralizing antibodies by comparing the in vitro neutralization of wild-type (wt) RSV versus recombinant mG RSV expressing only mG. wt RSV indeed was less susceptible than mG RSV to monovalent G-specific and polyvalent RSV-specific antibodies, whereas susceptibility to F-specific antibodies was equivalent. This difference disappeared when the virus preparations were purified to remove sG. Thus, sG appears to function as a neutralization decoy. We evaluated this effect in vivo in mice by comparing the effects of passively transferred antibodies on the pulmonary replication of wt RSV versus mG RSV. Again, wt RSV was less sensitive than mG RSV to G-specific and RSV-specific antibodies; however, a similar difference was also observed with F-specific antibodies. This confirmed that sG helps wt RSV evade the antibody-dependent restriction of replication but indicated that in mice, it is not acting primarily as a decoy for G-specific antibodies, perhaps because sG is produced in insufficient quantities in this poorly permissive animal. Rather, we found that the greater sensitivity of mG versus wt RSV to the antiviral effect of passively transferred RSV antibodies required the presence of inflammatory cells in the lung and was Fc gamma receptor dependent. Thus, sG helps RSV escape the antibody-dependent restriction of replication via effects as an antigen decoy and as a modulator of leukocytes bearing Fc gamma receptors.

Citing Articles

Interactions Between Bovine Respiratory Syncytial Virus and Cattle: Aspects of Pathogenesis and Immunity.

da Silva Barcelos L, Ford A, Fruhauf M, Botton N, Fischer G, Maggioli M Viruses. 2024; 16(11).

PMID: 39599867 PMC: 11598946. DOI: 10.3390/v16111753.


The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response.

Rivas-Fuentes S, Salgado-Aguayo A, Santos-Mendoza T, Sevilla-Reyes E Int J Mol Sci. 2024; 25(18).

PMID: 39337288 PMC: 11432029. DOI: 10.3390/ijms25189800.


Global progress in clinical research on human respiratory syncytial virus vaccines.

Peng R, Chen C, Chen Q, Zhang Y, Huang R, Zhang Y Front Microbiol. 2024; 15:1457703.

PMID: 39286350 PMC: 11402711. DOI: 10.3389/fmicb.2024.1457703.


Respiratory syncytial virus: A new era.

Ruiz-Galiana J, Canton R, De Lucas Ramos P, Garcia-Botella A, Garcia-Lledo A, Hernandez-Sampelayo T Rev Esp Quimioter. 2024; 37(2):134-148.

PMID: 38205560 PMC: 10945101. DOI: 10.37201/req/147.2023.


A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus.

Le Rouzic A, Fix J, Vinck R, Kappler-Gratias S, Volmer R, Gallardo F Int J Mol Sci. 2024; 25(1).

PMID: 38203585 PMC: 10778932. DOI: 10.3390/ijms25010415.


References
1.
Rooman R, Koster G, Bloemen R, Gresnigt R, van Buul-Offers S . The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice. J Endocrinol. 1999; 163(3):543-52. DOI: 10.1677/joe.0.1630543. View

2.
Wilson J, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn A . Epitopes involved in antibody-mediated protection from Ebola virus. Science. 2000; 287(5458):1664-6. DOI: 10.1126/science.287.5458.1664. View

3.
Choi E, Lee H . Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J Infect Dis. 2000; 181(5):1547-56. DOI: 10.1086/315468. View

4.
Wright P, Karron R, Belshe R, Thompson J, Crowe Jr J, Boyce T . Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis. 2000; 182(5):1331-42. DOI: 10.1086/315859. View

5.
Ray R, Hoft D, Meyer K, Brown R, Lagging L, Belshe R . Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. Virus Res. 2001; 75(2):147-54. DOI: 10.1016/s0168-1702(01)00237-4. View